{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:23:50Z","timestamp":1794201830488,"version":"4.8.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68718-4","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:23:00Z","timestamp":1770312180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma"],"prefix":"10.1038","volume":"17","author":[{"given":"Kane A.","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-0776","authenticated-orcid":false,"given":"Elise","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Ainley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9982-1086","authenticated-orcid":false,"given":"Annabel","family":"Laidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6092-8949","authenticated-orcid":false,"given":"Lydia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwennan","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-154X","authenticated-orcid":false,"given":"Daria","family":"Galas-Filipowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Fitzsimons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0603-6867","authenticated-orcid":false,"given":"Anna","family":"Mikolajczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7148-0027","authenticated-orcid":false,"given":"Dylan","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Turakhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipal","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Garrod-Ketchley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-3149","authenticated-orcid":false,"given":"Imran","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Hoade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-978X","authenticated-orcid":false,"given":"James L.","family":"Reading","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieuan","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-717X","authenticated-orcid":false,"given":"Javier","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7417-3970","authenticated-orcid":false,"given":"Benny","family":"Chain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-1700","authenticated-orcid":false,"given":"Sergio A.","family":"Quezada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6487-276X","authenticated-orcid":false,"given":"Kwee L.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"68718_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"68718_CR2","doi-asserted-by":"crossref","unstructured":"Kay Chung, H., McDonald, B. & Kaech, S. M. The architectural design of CD8+ T cell responses in acute and chronic infection: parallel structures with divergent fates. J. Exp. Med. 218, e20201730 (2021).","DOI":"10.1084\/jem.20201730"},{"key":"68718_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow, A., Perica, K., Klebanoff, C. A. & Wolchok, J. D. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat. Rev. Clin. Oncol. 19, 775\u2013790 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"68718_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"NWCJ van de Donk","year":"2021","unstructured":"van de Donk, N. W. C. J., Pawlyn, C. & Yong, K. L. Multiple myeloma. Lancet 397, 410\u2013427 (2021).","journal-title":"Lancet"},{"key":"68718_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-020-00366-3","volume":"10","author":"MV Mateos","year":"2020","unstructured":"Mateos, M. V. et al. International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM). Blood Cancer J. 10, 1\u201311 (2020).","journal-title":"Blood Cancer J."},{"key":"68718_CR6","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren, O. et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 113, 5412\u20135417 (2009).","journal-title":"Blood"},{"key":"68718_CR7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1158\/1078-0432.CCR-19-2111","volume":"26","author":"AD Cohen","year":"2020","unstructured":"Cohen, A. D. et al. How to train your T cells: overcoming immune dysfunction in multiple myeloma a C. Clin. Cancer Res. 26, 1541\u20131554 (2020).","journal-title":"Clin. Cancer Res."},{"key":"68718_CR8","first-page":"484","volume":"228","author":"DA Mogilenko","year":"2021","unstructured":"Mogilenko, D. A., Shchukina, I. & Artyomov, M. N. Immune ageing at single-cell resolution. Nat. Rev. Immunol. 228, 484\u2013498 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"68718_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri.2016.31","volume":"16","author":"F Di Rosa","year":"2016","unstructured":"Di Rosa, F. Maintenance of memory T cells in the bone marrow: survival or homeostatic proliferation? Nat. Rev. Immunol. 16, 271\u2013271 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"68718_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","volume":"39","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. Insights gained from single-cell analysis of immune cells in the tumor microenvironment. Annu. Rev. Immunol. 39, 583\u2013609 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"68718_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"68718_CR12","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp, P. R. et al. International staging system for multiple myeloma. J. Clin. Oncol. 23, 3412\u20133420 (2005).","journal-title":"J. Clin. Oncol."},{"key":"68718_CR13","first-page":"668919","volume":"08","author":"TR Wagner","year":"2025","unstructured":"Wagner, T. R. et al. Conserved programs and specificities of T cells targeting hematological malignancies. bioRxiv 08, 668919 (2025).","journal-title":"bioRxiv"},{"key":"68718_CR14","doi-asserted-by":"crossref","unstructured":"Friedrich, M. J. et al. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell 41, 711\u2013725 (2023).","DOI":"10.1016\/j.ccell.2023.02.008"},{"key":"68718_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1172\/JCI98888","volume":"129","author":"S Vuckovic","year":"2019","unstructured":"Vuckovic, S. et al. Bone marrow transplantation generates T cell\u2013dependent control of myeloma in mice. J. Clin. Invest. 129, 106\u2013121 (2019).","journal-title":"J. Clin. Invest."},{"key":"68718_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1158\/2326-6066.CIR-15-0055","volume":"4","author":"DJ Chung","year":"2016","unstructured":"Chung, D. J. et al. T-cell exhaustion in multiple myeloma relapse after autotransplant: optimal timing of immunotherapy. Cancer Immunol. Res. 4, 61\u201371 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"68718_CR17","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1200\/JCO.21.02228","volume":"40","author":"RM De Tute","year":"2022","unstructured":"De Tute, R. M. et al. Minimal residual disease after autologous stem-cell transplant for patients with myeloma: prognostic significance and the impact of lenalidomide maintenance and molecular risk. J. Clin. Oncol. 40, 2889\u20132900 (2022).","journal-title":"J. Clin. Oncol."},{"key":"68718_CR18","doi-asserted-by":"crossref","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","DOI":"10.1126\/science.abe6474"},{"key":"68718_CR19","doi-asserted-by":"crossref","unstructured":"Kourelis, T. V. et al. Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies. Blood Cancer J. 9, 72 (2019).","DOI":"10.1038\/s41408-019-0234-4"},{"key":"68718_CR20","doi-asserted-by":"crossref","unstructured":"Meermeier, E. W., Bergsagel, P. L. & Chesi, M. Next-generation therapies for multiple myeloma. Annu. Rev. Cancer Biol. 8, 351\u2013371 (2024).","DOI":"10.1146\/annurev-cancerbio-061421-014236"},{"key":"68718_CR21","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41590-020-0791-5","volume":"21","author":"G Galletti","year":"2020","unstructured":"Galletti, G. et al. Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans. Nat. Immunol. 21, 1552\u20131562 (2020).","journal-title":"Nat. Immunol."},{"key":"68718_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.immuni.2020.11.005","volume":"54","author":"DA Mogilenko","year":"2021","unstructured":"Mogilenko, D. A. et al. Comprehensive profiling of an aging immune system reveals clonal GZMK+ CD8+ T cells as conserved hallmark of inflammaging. Immunity 54, 99\u2013115.e12 (2021).","journal-title":"Immunity"},{"key":"68718_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ccell.2022.09.011","volume":"41","author":"WH Hudson","year":"2023","unstructured":"Hudson, W. H. & Wieland, A. Technology meets TILs: deciphering T cell function in the -omics era. Cancer Cell 41, 41\u201357 (2023).","journal-title":"Cancer Cell"},{"key":"68718_CR24","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood.2024025655","volume":"145","author":"C Shasha","year":"2025","unstructured":"Shasha, C. et al. Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy. Blood 145, 3113\u20133123 (2025).","journal-title":"Blood"},{"key":"68718_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adp6667","volume":"10","author":"R Lutz","year":"2025","unstructured":"Lutz, R. et al. Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma. Sci. Immunol. 10, eadp6667 (2025).","journal-title":"Sci. Immunol."},{"key":"68718_CR26","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ccell.2022.10.017","volume":"40","author":"R Sklavenitis-Pistofidis","year":"2022","unstructured":"Sklavenitis-Pistofidis, R. et al. Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer Cell 40, 1358\u20131373.e8 (2022).","journal-title":"Cancer Cell"},{"key":"68718_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","volume":"1","author":"O Zavidij","year":"2020","unstructured":"Zavidij, O. et al. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat. Cancer 1, 493\u2013506 (2020).","journal-title":"Nat. Cancer"},{"key":"68718_CR28","doi-asserted-by":"crossref","unstructured":"Bailur, J. K. et al. Early alterations in stem-like\/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy. JCI Insight 4, e127807 (2019).","DOI":"10.1172\/jci.insight.127807"},{"key":"68718_CR29","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ccell.2023.05.007","volume":"41","author":"M Dang","year":"2023","unstructured":"Dang, M. et al. Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease. Cancer Cell 41, 1032\u20131047.e4 (2023).","journal-title":"Cancer Cell"},{"key":"68718_CR30","doi-asserted-by":"publisher","unstructured":"Ludwig, H., Meckl, A. & Engelhardt, M. Compliance with vaccination recommendations among patients with multiple myeloma: a real world experience. HemaSphere https:\/\/doi.org\/10.1097\/HS9.0000000000000597 (2021).","DOI":"10.1097\/HS9.0000000000000597"},{"key":"68718_CR31","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1158\/0008-5472.CAN-04-3337","volume":"65","author":"K Noonan","year":"2005","unstructured":"Noonan, K. et al. Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors. Cancer Res. 65, 2026\u20132034 (2005).","journal-title":"Cancer Res."},{"key":"68718_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1158\/1078-0432.CCR-19-2309","volume":"26","author":"D Perumal","year":"2020","unstructured":"Perumal, D. et al. Mutation-derived neoantigen specific T cell responses in multiple myeloma. Clin. Cancer Res. 26, 450 (2020).","journal-title":"Clin. Cancer Res."},{"key":"68718_CR33","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1182\/bloodadvances.2020002237","volume":"4","author":"S Vuckovic","year":"2020","unstructured":"Vuckovic, S. et al. Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients. Blood Adv. 4, 4593\u20134604 (2020).","journal-title":"Blood Adv."},{"key":"68718_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41590-021-00931-3","volume":"226","author":"MME de Jong","year":"2021","unstructured":"de Jong, M. M. E. et al. The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nat. Immunol. 226, 769\u2013780 (2021).","journal-title":"Nat. Immunol."},{"key":"68718_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-4419-6451-9_15","volume":"684","author":"SM Henson","year":"2010","unstructured":"Henson, S. M. & Akbar, A. N. Memory T-cell homeostasis and senescence during aging. Adv. Exp. Med. Biol. 684, 189\u2013197 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"68718_CR36","doi-asserted-by":"crossref","unstructured":"Lee, L. et al. Increased immune-regulatory receptor expression on effector T cells as early indicators of relapse following autologous stem cell transplantation for multiple myeloma. Front. Immunol. 12, 618610 (2021).","DOI":"10.3389\/fimmu.2021.618610"},{"key":"68718_CR37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/76243","volume":"66","author":"A Trojan","year":"2000","unstructured":"Trojan, A. et al. Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. Nat. Med. 66, 667\u2013672 (2000).","journal-title":"Nat. Med."},{"key":"68718_CR38","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1172\/JCI88169","volume":"128","author":"Y Kawano","year":"2018","unstructured":"Kawano, Y. et al. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J. Clin. Invest. 128, 2487\u20132499 (2018).","journal-title":"J. Clin. Invest."},{"key":"68718_CR39","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1158\/1078-0432.CCR-19-1714","volume":"26","author":"N Alrasheed","year":"2020","unstructured":"Alrasheed, N. et al. Marrow-infiltrating regulatory T cells correlate with the presence of dysfunctional CD4\u00fePD-1\u00fe cells and inferior survival in patients with newly diagnosed multiple myeloma. Clin. Cancer Res. 26, 3443\u20133454 (2020).","journal-title":"Clin. Cancer Res."},{"key":"68718_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","volume":"205","author":"S M\u00e9ndez-Ferrer","year":"2020","unstructured":"M\u00e9ndez-Ferrer, S. et al. Bone marrow niches in haematological malignancies. Nat. Rev. Cancer 205, 285\u2013298 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"68718_CR41","doi-asserted-by":"crossref","unstructured":"Royle, K. L. et al. Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II\/III randomised controlled trial. BMJ Open 12, e063037 (2022).","DOI":"10.1136\/bmjopen-2022-063037"},{"key":"68718_CR42","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/S2352-3026(22)00350-7","volume":"10","author":"K Yong","year":"2023","unstructured":"Yong, K. et al. Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial. Lancet Haematol. 10, e93\u2013e106 (2023).","journal-title":"Lancet Haematol."},{"key":"68718_CR43","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","volume":"39","author":"Y Kfoury","year":"2021","unstructured":"Kfoury, Y. et al. Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell 39, 1464\u20131478.e8 (2021).","journal-title":"Cancer Cell"},{"key":"68718_CR44","first-page":"1","volume":"141","author":"C Botta","year":"2023","unstructured":"Botta, C. et al. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nat. Commun 141, 1\u201315 (2023).","journal-title":"Nat. Commun"},{"key":"68718_CR45","first-page":"1","volume":"121","author":"R Liu","year":"2021","unstructured":"Liu, R. et al. Co-evolution of tumor and immune cells during progression of multiple myeloma. Nat. Commun. 121, 1\u201318 (2021).","journal-title":"Nat. Commun."},{"key":"68718_CR46","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"275","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 275, 904\u2013916 (2021).","journal-title":"Nat. Med."},{"key":"68718_CR47","first-page":"376","volume":"80","author":"C Dom\u00ednguez Conde","year":"2022","unstructured":"Dom\u00ednguez Conde, C. et al. Cross-tissue immune cell analysis reveals tissue-specific features in humans. Science 80, 376 (2022).","journal-title":"Science"},{"key":"68718_CR48","doi-asserted-by":"crossref","unstructured":"Oetjen, K. A. et al. Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry. JCI Insight 3, e124928 (2018).","DOI":"10.1172\/jci.insight.124928"},{"key":"68718_CR49","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s43018-023-00657-1","volume":"412","author":"F Maura","year":"2023","unstructured":"Maura, F. et al. Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens. Nat. Cancer 412, 1660\u20131674 (2023).","journal-title":"Nat. Cancer"},{"key":"68718_CR50","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","volume":"3712","author":"JM Granja","year":"2019","unstructured":"Granja, J. M. et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Nat. Biotechnol. 3712, 1458\u20131465 (2019).","journal-title":"Nat. Biotechnol."},{"key":"68718_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: Large-scale single-cell gene expression data analysis. Genome Biol. 19, 1\u20135 (2018).","journal-title":"Genome Biol."},{"key":"68718_CR52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281\u2013291.e9 (2019).","journal-title":"Cell Syst."},{"key":"68718_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41587-021-01206-w","volume":"402","author":"A Gayoso","year":"2022","unstructured":"Gayoso, A. et al. A Python library for probabilistic analysis of single-cell omics data. Nat. Biotechnol. 402, 163\u2013166 (2022).","journal-title":"Nat. Biotechnol."},{"key":"68718_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1561\/2200000090","volume":"14","author":"A Agrawal","year":"2021","unstructured":"Agrawal, A., Ali, A. & Boyd, S. Minimum-distortion embedding. Found. Trends Mach. Learn. 14, 211\u2013378 (2021).","journal-title":"Found. Trends Mach. Learn."},{"key":"68718_CR55","doi-asserted-by":"crossref","unstructured":"Ara\u00fazo-Bravo, M. J., Izeta, A. & Ascensi\u00f3n, A. M. The need to reassess single-cell RNA sequencing datasets: the importance of biological sample processing. F1000Res. 10, 767 (2021).","DOI":"10.12688\/f1000research.54864.1"},{"key":"68718_CR56","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","volume":"296","author":"Y Chu","year":"2023","unstructured":"Chu, Y. et al. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat. Med. 296, 1550\u20131562 (2023).","journal-title":"Nat. Med."},{"key":"68718_CR57","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. & Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. Comput. Struct. Biotechnol. J. 19, 3796\u20133798 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"68718_CR58","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/s41590-023-01575-1","volume":"249","author":"LC Garner","year":"2023","unstructured":"Garner, L. C. et al. Single-cell analysis of human MAIT cell transcriptional, functional and clonal diversity. Nat. Immunol. 249, 1565\u20131578 (2023).","journal-title":"Nat. Immunol."},{"key":"68718_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/giz107","volume":"8","author":"TP Quinn","year":"2019","unstructured":"Quinn, T. P. et al. A field guide for the compositional analysis of any-omics data. Gigascience 8, 1\u201314 (2019).","journal-title":"Gigascience"},{"key":"68718_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.chemolab.2015.02.019","volume":"143","author":"J Palarea-Albaladejo","year":"2015","unstructured":"Palarea-Albaladejo, J. & Mart\u00edn-Fern\u00e1ndez, J. A. zCompositions\u2014R package for multivariate imputation of left-censored data under a compositional approach. Chemom. Intell. Lab. Syst. 143, 85\u201396 (2015).","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"68718_CR61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.2517-6161.1982.tb01195.x","volume":"44","author":"J Aitchison","year":"1982","unstructured":"Aitchison, J. The statistical analysis of compositional data. J. R. Stat. Soc. Ser. B 44, 139\u2013160 (1982).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"68718_CR62","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","volume":"296","author":"L Sikkema","year":"2023","unstructured":"Sikkema, L. et al. An integrated cell atlas of the lung in health and disease. Nat. Med. 296, 1563\u20131577 (2023).","journal-title":"Nat. Med."},{"key":"68718_CR63","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/163688a0","volume":"163","author":"EH Simpson","year":"1949","unstructured":"Simpson, E. H. Measurement of diversity [16]. Nature 163, 688 (1949).","journal-title":"Nature"},{"key":"68718_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature22383","volume":"547","author":"P Dash","year":"2017","unstructured":"Dash, P. et al. Quantifiable predictive features define epitope specific T cell receptor repertoires. Nature 547, 89 (2017).","journal-title":"Nature"},{"key":"68718_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/bioinformatics\/btz474","volume":"36","author":"R Orenbuch","year":"2020","unstructured":"Orenbuch, R. et al. arcasHLA: high-resolution HLA typing from RNAseq. Bioinformatics 36, 33\u201340 (2020).","journal-title":"Bioinformatics"},{"key":"68718_CR66","doi-asserted-by":"publisher","first-page":"D1057","DOI":"10.1093\/nar\/gkz874","volume":"48","author":"DV Bagaev","year":"2020","unstructured":"Bagaev, D. V. et al. VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium. Nucleic Acids Res. 48, D1057\u2013D1062 (2020).","journal-title":"Nucleic Acids Res."},{"key":"68718_CR67","doi-asserted-by":"publisher","first-page":"250318","DOI":"10.3389\/fimmu.2017.00278","volume":"8","author":"W Fleri","year":"2017","unstructured":"Fleri, W. et al. The immune epitope database and analysis resource in epitope discovery and synthetic vaccine design. Front. Immunol. 8, 250318 (2017).","journal-title":"Front. Immunol."},{"key":"68718_CR68","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkac902","volume":"51","author":"Z Ko\u015falo\u01e7lu-Yal\u00e7\u0131n","year":"2023","unstructured":"Ko\u015falo\u01e7lu-Yal\u00e7\u0131n, Z. et al. The Cancer Epitope Database and Analysis Resource (CEDAR). Nucleic Acids Res. 51, D845\u2013D852 (2023).","journal-title":"Nucleic Acids Res."},{"key":"68718_CR69","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41591-019-0592-2","volume":"2510","author":"K Joshi","year":"2019","unstructured":"Joshi, K. et al. Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer. Nat. Med. 2510, 1549\u20131559 (2019).","journal-title":"Nat. Med."},{"key":"68718_CR70","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","volume":"110","author":"D Gonz\u00e1lez","year":"2007","unstructured":"Gonz\u00e1lez, D. et al. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood 110, 3112\u20133121 (2007).","journal-title":"Blood"},{"key":"68718_CR71","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/leu.2013.12","volume":"278","author":"MF Kaiser","year":"2013","unstructured":"Kaiser, M. F. et al. A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR. Leukemia 278, 1754\u20131757 (2013).","journal-title":"Leukemia"},{"key":"68718_CR72","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"6187965","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 6187965, 598\u2013606 (2023).","journal-title":"Nature"},{"key":"68718_CR73","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nmeth.4077","volume":"13","author":"D T\u00fcrei","year":"2016","unstructured":"T\u00fcrei, D., Korcsm\u00e1ros, T. & Saez-Rodriguez, J. OmniPath: guidelines and gateway for literature-curated signaling pathway resources. Nat. Methods 13, 966\u2013967 (2016).","journal-title":"Nat. Methods"},{"key":"68718_CR74","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3324\/haematol.2019.235424","volume":"106","author":"MA Bauer","year":"2021","unstructured":"Bauer, M. A. et al. Differential RNA splicing as a potentially important driver mechanism in multiple myeloma. Haematologica 106, 736\u2013745 (2021).","journal-title":"Haematologica"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68718-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68718-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68718-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:04:13Z","timestamp":1773331453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68718-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68718"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68718-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2400"}}